Sanofi swoops on Ablynx as M&A spree up
French pharmaceutical company Sanofi has announced its second multi-billion euro takeover this month, offering to buy Belgian biotech company Ablynx for €3.9bn in cash.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts